RCKT NASDAQ
Rocket Pharmaceuticals, Inc.
1W: -1.5%
1M: -33.7%
3M: -35.8%
YTD: -26.0%
1Y: -19.0%
3Y: -88.0%
5Y: -92.0%
$2.56
-0.03 (-1.16%)
Weekly Expected Move ±8.2%
$2
$2
$3
$3
$3
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
3 relationships0
As Filer
counterparties named
3
As Counterparty
mentioned by others
2022-09-20
Earliest Filing
2025-05-19
Latest Filing
Mentioned As Counterparty
3 mentionsOther companies that named RCKT in their SEC 8-K filings.
| Filed By | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|
| RGNX REGENXBIO Inc. | licensee | Licensee of Company NAV® vectors under an existing license agreement. | 2025-05-19 | View |
| RCKTW ROCKET PHARMACEUTICALS, INC. | target | Parent company acquiring Renovacor in a merger transaction | 2022-12-01 | View |
| RCKTW ROCKET PHARMACEUTICALS, INC. | target | Parent company entering into a merger agreement | 2022-09-20 | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR